Original Investigation
Dialysis
Association of Residual Urine Output With Mortality, Quality of Life, and Inflammation in Incident Hemodialysis Patients: The Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study

https://doi.org/10.1053/j.ajkd.2010.03.020Get rights and content

Background

Residual kidney function (RKF) is associated with improved survival in peritoneal dialysis patients, but its role in hemodialysis patients is less well known. Urine output may provide an estimate of RKF. The aim of our study is to determine the association of urine output with mortality, quality of life (QOL), and inflammation in incident hemodialysis patients.

Study Design

Nationally representative prospective cohort study.

Setting & Participants

734 incident hemodialysis participants treated in 81 clinics; enrollment, 1995-1998; follow-up until December 2004.

Predictor

Urine output, defined as producing at least 250 mL (1 cup) of urine daily, ascertained using questionnaires at baseline and year 1.

Outcomes & Measurements

Primary outcomes were all-cause and cardiovascular mortality, analyzed using Cox regression adjusted for demographic, clinical, and treatment characteristics. Secondary outcomes were QOL, inflammation (C-reactive protein and interleukin 6 levels), and erythropoietin (EPO) requirements.

Results

617 of 734 (84%) participants reported urine output at baseline, and 163 of 579 (28%), at year 1. Baseline urine output was not associated with survival. Urine output at year 1, indicating preserved RKF, was independently associated with lower all-cause mortality (HR, 0.70; 95% CI, 0.52-0.93; P = 0.02) and a trend toward lower cardiovascular mortality (HR, 0.69; 95% CI, 0.45-1.05; P = 0.09). Participants with urine output at baseline reported better QOL and had lower C-reactive protein (P = 0.02) and interleukin 6 (P = 0.03) levels. Importantly, EPO dose was 12,000 U/wk lower in those with urine output at year 1 compared with those without (P = 0.001).

Limitations

Urine volume was measured in only a subset of patients (42%), but agreed with self-report (P < 0.001).

Conclusions

RKF in hemodialysis patients is associated with better survival and QOL, lower inflammation, and significantly less EPO use. RKF should be monitored routinely in hemodialysis patients. The development of methods to assess and preserve RKF is important and may improve dialysis care.

Section snippets

Study Design

The CHOICE Study is a nationally representative prospective cohort study of incident dialysis patients.11 From October 1995 to June 1998, a total of 1,041 participants from 19 US states were enrolled, 767 of whom were on HD therapy. CHOICE patients were followed up through December 31, 2004. Eligibility criteria were new onset of long-term dialysis therapy in the preceding 3 months, ability to provide informed consent, age older than 18 years, and ability to speak English or Spanish. The Johns

Participant Characteristics

Baseline characteristics of participants stratified by urine output at baseline and year 1 are listed in Table 1. Individuals with urine output were more likely to be white, have undergone earlier nephrologist evaluation, have higher systolic blood pressure and pulse pressure, and be receiving diuretics compared with those without urine output. Participants with missing urine output information at baseline (n = 33 [4%]) were more likely to be older (P = 0.008) and have more comorbid conditions (

Discussion

To date, very few large representative studies have reported on the role of RKF in HD patients, particularly in the United States. This analysis of urine output from a national prospective cohort study of incident dialysis patients shows several important findings. RKF, identified using self-reported urine output, was reliable and was independently associated with lower all-cause mortality in HD patients. The survival benefit was especially notable in participants who had preserved urine output

Acknowledgements

We thank the patients, staff, laboratory, and physicians of Dialysis Clinic Inc, New Haven CAPD, and St Raphael's Hospital for their participation in the CHOICE Study; and the Cardiovascular Endpoint Committee, which, in addition to authors Jaar, Coresh, Fink, Plantinga, and Powe, includes Michael J. Choi, MD; Joseph A. Eustace, MD, MHS; Caroline Fox, MD, MPH; Melanie H. Katzman, MD, MHS; Michael J. Klag, MD, MPH; Yongmei Liu, MD, PhD; J. Craig Longenecker, MD, PhD; Michal Melamed, MD, MHS;

References (39)

  • R. Pecoits-Filho et al.

    Associations between circulating inflammatory markers and residual renal function in CRF patients

    Am J Kidney Dis.

    (2003)
  • A.Y. Wang et al.

    Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients

    Am J Kidney Dis.

    (2005)
  • M. Arici et al.

    End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link?

    Kidney Int.

    (2001)
  • J.L. Bragg-Gresham et al.

    Diuretic use, residual renal function, and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS)

    Am J Kidney Dis.

    (2007)
  • C.J. Konings et al.

    Fluid status in CAPD patients is related to peritoneal transport and residual renal function: evidence from a longitudinal study

    Nephrol Dial Transplant.

    (2003)
  • F. Termorshuizen et al.

    Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2

    J Am Soc Nephrol.

    (2004)
  • J.P. Tian et al.

    Residual renal function and arterial stiffness mediated the blood pressure change during interdialytic weight gain in hemodialysis patients

    Hemodial Int.

    (2009)
  • A.Y. Wang

    The “heart” of peritoneal dialysis

    Perit Dial Int.

    (2007)
  • K/DOQI Clinical Practice Guidelines for Hemodialysis Adequacy, update 2006

    Am J Kidney Dis

    (2006)
  • Cited by (237)

    • Physical Resilience Phenotype Trajectories in Incident Hemodialysis: Characterization and Mortality Risk Assessment

      2022, Kidney International Reports
      Citation Excerpt :

      Covariates were included based on associations with mortality in previous dialysis research. Body mass index (in kg/m2) was based on height and weight reported on the Health Care Financing Administration Medical Evidence Report (HCFA Form 2728).17 Kidney disease specific markers selected included the following: (i) type of vascular access, by category: arteriovenous fistula or graft, or central venous catheter or unknown;25 (ii) predialysis initiation nephrology consult timing (early [>12 months], intermediate [4–12 months], late [<4 months], unclassified, or missing)26; (iii) laboratory values for serum albumin (g/dl) obtained from HCFA Form 2728;27 and (iv) estimated glomerular filtration rate, calculated using the 4-variable Modification of Diet in Renal Disease Study equation.28

    View all citing articles on Scopus

    Originally published online as doi:10.1053/j.ajkd.2010.03.020 on June 4, 2010.

    Because the Editor-in-Chief recused himself from consideration of this manuscript, the Deputy Editor (Daniel E. Weiner, MD, MS) served as Acting Editor-in-Chief. Details of the journal's procedures for potential editor conflicts are given in the Editorial Policies section of the AJKD website.

    View full text